Table 3

Associations between modifiable dietary factors and polyp risk; the Tennessee Colorectal Polyp Study

Case–control comparisonsCase–case comparisons
No-polyp controlsHyperplastic polyps (HPs)Conventional adenomas (ADs)Sessile serrated polyps (SSPs)AD vs HPSSP vs HPSSP vs AD
Dietary intake (per day)nnOR (95% CI)nOR (95% CI)nOR (95% CI)OR (95% CI)OR (95% CI)OR (95% CI)
Fibre (g)*
 2.91–12.888131141.00 (ref)3751.00 (ref)571.00 (ref)1.00 (ref)1.00 (ref)1.00 (ref)
 12.88–17.798111271.01 (0.75 to 1.38)3190.72 (0.58 to 0.89)470.50 (0.30 to 0.82)0.71 (0.51 to 0.99)0.49 (0.28 to 0.86)0.69 (0.41 to 1.15)
 17.79–24.738111130.81 (0.57 to 1.15)3800.75 (0.59 to 0.94)370.64 (0.38 to 1.08)0.92 (0.64 to 1.34)0.79 (0.43 to 1.44)0.85 (0.50 to 1.46)
 >24.738111180.71 (0.48 to 1.05)4280.65 (0.50 to 0.85)470.46 (0.19 to 0.68)0.92 (0.60 to 1.40)0.51 (0.25 to 1.04)0.56 (0.29 to 1.06)
 ptrend0.050.0040.0060.960.170.12
Dietary folate equivalents (µg)*
 63.8–394.78121191.00 (ref)3691.00 (ref)481.00 (ref)1.00 (ref)1.00 (ref)1.00 (ref)
 394.7–572.68111230.88 (0.64 to 1.21)3480.74 (0.59 to 0.91)480.99 (0.60 to 1.65)0.83 (0.59 to 1.18)1.12 (0.64 to 1.99)1.35 (0.80 to 2.26)
 572.6–811.88111190.68 (0.47 to 0.97)3800.64 (0.50 to 0.81)460.83 (0.47 to 1.47)0.94 (0.64 to 1.38)1.23 (0.65 to 2.32)1.30 (0.73 to 2.33)
 >811.88121110.53 (0.35 to 0.80)4050.56 (0.43 to 0.73)360.51 (0.26 to 0.98)1.05 (0.68 to 1.61)0.96 (0.46 to 2.00)0.91 (0.47 to 1.78)
 ptrend<0.001<0.0010.030.620.940.69
Calcium (mg)*
 128.0–595.88121181.00 (ref)3701.00 (ref)531.00 (ref)1.00 (ref)1.00 (ref)1.00 (ref)
 595.8–837.88111170.91 (0.66 to 1.26)3420.80 (0.65 to 1.00)320.70 (0.42 to 1.19)0.88 (0.63 to 1.24)0.77 (0.43 to 1.38)0.87 (0.51 to 1.50)
 837.8–12178111120.68 (0.47 to 0.99)3900.68 (0.54 to 0.88)550.99 (0.56 to 1.76)1.00 (0.67 to 1.48)1.45 (0.76 to 2.76)1.45 (0.81 to 2.59)
 >12178121250.66 (0.44 to 0.99)4000.57 (0.43 to 0.75)380.54 (0.28 to 1.06)0.86 (0.56 to 1.33)0.83 (0.40 to 1.74)0.96 (0.49 to 1.88)
 ptrend0.03<0.0010.130.640.900.88
Fat (g)*
 11.91–48.00812911.00 (ref)2991.00 (ref)381.00 (ref)1.00 (ref)1.00 (ref)1.00 (ref)
 48.00–68.068101101.24 (0.85 to 1.80)2930.85 (0.66 to 1.09)361.40 (0.77 to 2.55)0.69 (0.46 to 1.03)1.13 (0.57 to 2.22)1.64 (0.88 to 3.04)
 68.06–98.168121261.23 (0.77 to 1.95)3860.89 (0.66 to 1.21)442.32 (1.07 to 5.04)1.00 (0.44 to 1.19)1.89 (0.80 to 4.50)2.60 (1.18 to 5.76)
 >98.168121451.19 (0.69 to 2.06)5240.97 (0.67 to 1.39)603.09 (1.24 to 7.72)0.86 (0.45 to 1.46)2.61 (0.94 to 7.23)3.20 (1.26 to 8.12)
 ptrend0.620.990.010.640.050.02
Red meat (g)*
 0–16.06811731.00 (ref)2261.00 (ref)251.00 (ref)1.00 (ref)1.00 (ref)1.00 (ref)
 16.06–38.548091121.53 (1.10 to 2.12)3581.42 (1.15 to 1.76)331.42 (0.79 to 2.57)0.93 (0.65 to 1.33)0.93 (0.48 to 1.79)1.00 (0.55 to 1.83)
 38.54–73.388071231.51 (1.08 to 2.10)3601.36 (1.10 to 1.69)472.32 (1.32 to 4.08)0.90 (0.63 to 1.30)1.54 (0.82 to 2.90)1.70 (0.95 to 3.04)
 >73.388081631.68 (1.19 to 2.37)5521.67 (1.34 to 2.09)733.38 (1.90 to 6.00)1.00 (0.69 to 1.44)2.02 (1.06 to 3.83)2.02 (1.13 to 3.63)
 ptrend0.009<0.001<0.0010.930.0060.003
  • *Derived from multinomial logistic regression models which included all case and control groups and adjusted for age based on categories (ages 40–49, 50–59, 60–64 and 65+), sex, educational attainment, year of colonoscopy, study site, cigarette use, non-steroidal anti-inflammatory drug use status and total daily energy intake (divided into quartile categories based on kcal/day).